On Wednesday, Endo International PLC announced an agreement to pay $830 million in compensatory funds for women who claim they have been injured by transvaginal mesh devices manufactured by its American Medical Systems subsidiary. In a statement, Endo announced that this money should cover a "substantial majority" of claims. The company did not, however admit that it was at fault in the issue.
Tens of thousands of lawsuits have been filed against the various medical companies responsible for these devices. Designed to treat such conditions as stress urinary incontinence and pelvic organ prolapse, transvaginal mesh devices have been linked to a number of severe side effects, including bleeding, pain during intercourse and / or urination, and even damage to the pelvic organs. Some patients have been forced to undergo corrective surgery in order to remedy the adverse effects of the device.
Endo and AMS had been the subject of about 22,000 transvaginal mesh lawsuits as of February 20, 2014. Last year, the company paid $54.5 million in order to settle additional cases regarding the device. They announced that they had set aside $520 million to deal with compensation for the claims. The settlement announced Wednesday, April 30, 2014, will be distributed over the course of the next year, according to an attorney representing some plaintiffs. Claimants are still required to adhere to certain points of protocol in order to obtain compensation for their injuries, including the procurement of medical records confirming injuries caused by the mesh devices.
Endo further claimed in the company's statement that it will be sustaining a $625 million charge — prior to taxes — in the first quarter to offset the settlement's cost.
Other medical manufacturers, including Johnson & Johnson's Ethicon unit and C.R. Bard Inc, are still facing unresolved cases regarding transvaginal mesh devices they have produced.